Study on the relationship between the breath acetaldehyde/ethanol ratio and the severity of NAFLD

Study on the relationship between the breath acetaldehyde/ethanol ratio and the severity of NAFLD - Relationship between the breath acetaldehyde/ethanol ratio and NAFLD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042694

Enrollment

300

Registered

2020-12-10

Start date

2020-12-10

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

nonalcoholic fatty liver disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. NAFLD patients who will receive FibroScan 2. Age over 20 yrs 3. AST, ALT, GGT under 5 ULN 4. alcohol intake male: less than 30g/day (210g/wk) female: less than 20g/day (140g/wk) 5. patients who cannot consent

Exclusion criteria

Exclusion criteria: 1. allelgy for alcohol 2. pregnant or breast-feeding women 3. severe complication 4. patients with pacemaker 5. HBV or HCV infection 6. history of Gastrointestinal surgery 7. enrolling at other studies 8. not applicable by judgment of physicians 9. decompensated cirrhosis

Design outcomes

Primary

Measure	Time frame
Relationship between A/E ration and NAFLD severity	—

Secondary

Measure	Time frame
Relationship between SNPs and NAFLD severity	—

Countries

Japan

Contacts

Public ContactYoshio Sumida

Aichi Medical University Department of Hepatology and Pancreatology

sumida@koto.kpu-m.ac.jp0561-62-3311

Outcome results